Alpine Woods Capital Investors’s Amedisys AMED Stock Holding History

Alpine Woods Capital Investors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,158	Closed	-$3.22M	–	219
2021 Q2	$3.22M	Hold	13,158	–	–	0.33%	103
2021 Q1	$3.48M	Hold	13,158	–	–	0.39%	89
2020 Q4	$3.86M	Sell	13,158 -200	-1%	-$51.3K	0.47%	77
2020 Q3	$3.16M	Sell	13,358 -2,300	-15%	-$523K	0.48%	74
2020 Q2	$3.11M	Sell	15,658 -400	-2%	-$74.6K	0.6%	50
2020 Q1	$2.95M	Buy	16,058 +100	+0.6%	+$17.8K	0.66%	36
2019 Q4	$2.66M	Buy	15,958 +8	+0.1%	+$1.19K	0.51%	50
2019 Q3	$2.09M	Hold	15,950	–	–	0.39%	56
2019 Q2	$1.94M	Hold	15,950	–	–	0.4%	62
2019 Q1	$1.97M	Sell	15,950 -400	-2%	-$50.2K	0.43%	56
2018 Q4	$1.92M	Sell	16,350 -300	-2%	-$35.4K	0.46%	52
2018 Q3	$2.08M	Buy	+16,650	New	+$1.84M	0.43%	64

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Alpine Woods Capital Investors's AMED Position: Q3 2021 in Review

Alpine Woods Capital Investors sold out of Amedisys (AMED) in Q3 2021, closing a stake of 13,158 shares — an estimated $3.22M sold.

Alpine Woods Capital Investors first reported a position in AMED in Q3 2018 and held it in 12 quarters. The position peaked at $3.86M in Q4 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

Alpine Woods Capital Investors reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
Alpine Woods Capital Investors sold 13,158 Amedisys shares in Q3 2021, an estimated $3.22M.
Alpine Woods Capital Investors first reported a position in Amedisys in Q3 2018 and held it in 12 quarters.
Alpine Woods Capital Investors's Amedisys position peaked at $3.86M in Q4 2020.
352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Alpine Woods Capital Investors's 13F filing for Q3 2021, filed 12 Nov 2021.